This week on dvm360.com: First case of spontaneous jaw growth reported, and other veterinary news

Good morning and happy Friday dvm360 readers! To all our Kansas City Chiefs and San Francisco 49ers fans out there, or those who are just tuning into the Super Bowl to see if Taylor Swift makes it from Tokyo or not, happy Super Bowl weekend! Be sure to listen to our recent episode of The Vet Blast Podcast with Renee Schmid, DVM, DABT, DABVT, senior toxicologist for the Pet Poison Helpline, as she discusses toxins that are lurking at Super Bowl gatherings to help clients keep their pets healthy and happy.

Here is what was popular this week on dvm360.com:

• Tyson, a 3-month-old French bulldog, was scheduled to go to Cornell University to meet with the dentistry and oral services for cleft palate surgery when his primary care veterinarian discovered a cancerous tumor on his jaw. After having a major portion of his jaw removed, the team would soon discover that his jaw had spontaneously grown back, making him the first reported case of jaw regrowth.
• Melissa King, PharmD, and Andrew Filewicz, PharmD, explain the new standards of practice being enforced by the FDA, accreditation organizations, and local state boards of pharmacy for Chapter <795> and Chapter <797>.
• On this weeks episode of The Vet Blast Podcast, host Adam Christman, DVM, MBA, and Wendy Myers, CVJ, president of Communication Solutions for Veterinarians, explained how veterinary clinics can successfully charge for technician appoints.
• The University of Wisconsin School of Veterinary Medicine recently conducted a study on the vision habits of dogs based on an owner survey published in Applied Animal Behaviour Science to determine the factors influences a dog's interest in interacting with video content.
• Because French bulldogs are rising in popularity for pet owners across the United States, a careful history collected from clients and education for them on common illnesses seen in the breed can help support their health. Learn more in this article recapping a lecture from the Veterinary Meeting & Expo in Orlando, Florida.
• The FDA announced this week that it will not object to temporary importation of Pluset, a porcine pituitary-derived follicle-stimulating hormone and luteinizing hormone, as the United States is experiencing a shortage of the FDA-approved follicle-stimulating hormone (FSH) Folltropin.
• And more!